Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Niger J Clin Pract ; 18(5): 693-7, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26096253

RESUMEN

Thyrotropin (thyroid stimulating hormone [TSH]) secreting pituitary adenomas (TSHoma) are rare adenomas presenting with hyperthyroidism due to impaired negative feedback of thyroid hormone on the pituitary and inappropriate TSH secretion. This article presents a case of TSH-secreting macroadenoma without any clinical hyperthyroidism symptoms accompanying immunoreaction with growth hormone (GH) and prolactin. A 36-year-old female patient was admitted with complaints of irregular menses and blurred vision. On physical exam, she had bitemporal hemianopsia defect. Magnetic resonance imaging (MRI) evaluation showed suprasellar macroadenoma measuring 33 mm × 26 mm × 28 mm was detected on pituitary MRI. She had no hyperthyroidism symptoms clinically. Although free T4 and free T3 levels were elevated, TSH level was inappropriately within the upper limit of normal. Response to T3 suppression and thyrotropin releasing hormone-stimulation test was inadequate. Other pituitary hormones were normal. Transsphenoidal adenomectomy was performed due to parasellar compression findings. Immunohistochemically widespread reaction was observed with TSH, GH and prolactin in the adenoma. The patient underwent a second surgical procedure 2 months later due to macroscopic residual tumor, bitemporal hemianopsia and a suprasellar homogenous uptake with regular borders on indium-111 octreotide scintigraphy. After second surgery; due to ongoing symptoms and residual tumor, she was managed with octreotide and cabergoline treatment. On her follow-up with medical treatment, TSH and free T4 values were within normal limits. Although silent TSHomas are rare, they may arise with compression symptoms as in our case. The differential diagnosis of secondary hyperthyroidism should include TSHomas and thyroid hormone receptor resistance syndrome.


Asunto(s)
Adenoma/metabolismo , Neoplasias Hipofisarias/metabolismo , Tirotropina/metabolismo , Adenoma/complicaciones , Adenoma/diagnóstico por imagen , Adulto , Femenino , Humanos , Hipertiroidismo , Inmunohistoquímica , Imagen por Resonancia Magnética , Octreótido/análogos & derivados , Hipófisis/diagnóstico por imagen , Neoplasias Hipofisarias/cirugía , Prolactina , Pruebas de Función de la Tiroides , Tirotropina/sangre
2.
Eur Surg Res ; 44(3-4): 142-51, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20203520

RESUMEN

BACKGROUND: The purpose of this study was to evaluate skin graft integrity after external beam irradiation in a rat model. METHODS: Forty-eight male Wistar rats were randomly assigned to 8 groups (A, B, C, D, A(c), B(c), C(c) and D(c)). A rectangular full-thickness skin graft was raised and reapplied to its original bed on the dorsum of each rat. Groups A(c), B(c), C(c) and D(c) were the control groups and were not given postoperative irradiation. After grafting, 25 Gy unfractioned cobalt(60) irradiation was administered to groups A, B, C and D on postoperative days 10, 20, 30 and 40, respectively. Histological samples were obtained 8 weeks after grafting. Dermal and epidermal thickness were measured by the KS-400 image analysis program. RESULTS: The difference in the epidermal and/or dermal thickness between the irradiated groups was not found to be significant. Furthermore, when histological features and the image analysis of the irradiated groups were compared with each other, there were no significant differences between the groups. CONCLUSIONS: Although we are aware that experimental results may not directly translate to the clinical setting, the present study indicates that external radiotherapy can be performed to skin-grafted areas as early as 10 days postoperatively.


Asunto(s)
Supervivencia de Injerto/efectos de la radiación , Trasplante de Piel , Animales , Radioisótopos de Cobalto/uso terapéutico , Relación Dosis-Respuesta en la Radiación , Humanos , Masculino , Modelos Animales , Radioterapia Adyuvante/efectos adversos , Ratas , Ratas Wistar , Trasplante de Piel/patología , Neoplasias de los Tejidos Blandos/radioterapia , Neoplasias de los Tejidos Blandos/cirugía , Factores de Tiempo , Trasplante Autólogo
3.
J Laryngol Otol ; 123(12): 1381-3, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19470188

RESUMEN

OBJECTIVE: We report an extremely rare case of distant metastasis to the rectus femoris muscle from a laryngeal squamous cell carcinoma. METHOD: We present a case report and a review of the world literature concerning distant skeletal muscle metastasis from head and neck squamous cell carcinoma. RESULTS: The patient showed no evidence of distant muscular recurrence at follow up after 21 months; however, two years later he died from brain and suprarenal metastases. CONCLUSION: This report describes the first case of haematogenous distant metastasis to the left rectus femoris muscle from a laryngeal squamous cell carcinoma, without evidence of cervical lymph node metastases. To the best of our knowledge, this is the second reported case of muscular distant metastasis without cervical lymph node involvement. Although the prognosis associated with skeletal muscle metastasis is considered to be poor, surgical excision may be indicated for an isolated muscular metastasis.


Asunto(s)
Carcinoma de Células Escamosas/secundario , Neoplasias Laríngeas/patología , Neoplasias de los Músculos/secundario , Músculo Cuádriceps , Anciano , Resultado Fatal , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda